NCT06798363 2026-03-16
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
West China Hospital
Phase 2/3 Recruiting
Clinical Trials
57 trialsNCT06120140 2026-03-13
COCOON
Janssen Research & Development, LLC
Phase 2 Recruiting
NCT05561751 2026-02-12
Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant
GPCR Therapeutics, Inc.
Phase 2 Completed
NCT05797662 2026-01-23
A Study of Propranolol to Treat Kaposi Sarcoma
AIDS Malignancy Consortium
Phase 2 Not yet recruiting
NCT07353294 2026-01-20
Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1 Not yet recruiting
NCT05312255 2025-12-01
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Roswell Park Cancer Institute
Phase NA Recruiting
NCT05968690 2025-09-18
Naltrexone and Propranolol Combined With Immunotherapy
Rutgers, The State University of New Jersey
Phase 1 Recruiting
NCT06445166 2025-08-28
Propranolol for the Treatment of Kaposi Sarcoma in Adults
Washington University School of Medicine
Phase 2 Recruiting
NCT06670976 2025-08-26
Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma
Roswell Park Cancer Institute
Phase 1 Withdrawn
NCT06839144 2025-07-11
OC-POP-PT
Tel-Aviv Sourasky Medical Center
Phase 2 Recruiting
NCT05451043 2025-06-26
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
AHS Cancer Control Alberta
Phase 2 Recruiting
NCT05429970 2025-05-18
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT03152786 2025-02-17
Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Wake Forest University Health Sciences
Phase 2 Terminated
NCT06775080 2025-01-14
The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors
Huashan Hospital
Phase 2 Recruiting
NCT05979818 2024-11-19
BRIO
Second Xiangya Hospital of Central South University
Phase 1 Recruiting
NCT05679193 2024-05-29
PeP-RALP
Oslo University Hospital
Phase 2 Completed
NCT02641314 2024-05-10
METRO-NB2012
University of Cologne
Phase 2 Completed
NCT03474614 2024-04-19
Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation
St. Joseph's Hospital and Medical Center, Phoenix
Phase 2 Terminated
NCT06145074 2024-03-28
IMPULS
Zealand University Hospital
Phase 2 Recruiting
NCT04518124 2023-11-22
Propranolol in Angiosarcoma
The Netherlands Cancer Institute
Phase 2 Completed
NCT05327309 2023-09-13
Role of Propranolol as Compared to Bleomycin in Management of Hemangioma
Shaheed Zulfiqar Ali Bhutto Medical University
Phase NA Completed
NCT05961761 2023-07-27
PROPANE
Herlev and Gentofte Hospital
Phase 2 Recruiting
NCT02342275 2022-06-16
Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma
West China Hospital
Phase 3 Completed
NCT03589014 2022-02-25
Treat_CCM
Mario Negri Institute for Pharmacological Research
Phase 2 Completed
NCT05106179 2021-11-03
The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma
Center for Vascular Pathology, Moscow
Phase 4 Unknown
NCT01902966 2021-10-12
Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)
M.D. Anderson Cancer Center
Phase NA Terminated
NCT01847001 2021-09-10
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Columbia University
Phase 2 Completed
NCT02420223 2021-06-07
Study of Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in HCT Recipients
Medical College of Wisconsin
Phase 2 Completed
NCT02505971 2020-10-28
Nadolol Versus Propranolol in Children With Infantile Hemangiomas
The Hospital for Sick Children
Phase 3 Completed
NCT04493489 2020-07-30
Propranolol Adjuvant Treatment of Bladder Cancer
Central South University
Phase 2 Unknown
NCT04288700 2020-02-28
Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary Hemangioma
Ain Shams University
Phase 4 Unknown
NCT04005365 2019-11-26
Clinical Study of Propranolol Combined With Neoadjuvant Chemotherapy in Gastric Cancer
Central South University
Phase 2 Unknown
NCT03838029 2019-11-20
BC-PC
Assaf-Harofeh Medical Center
Phase 2 Unknown
NCT01451658 2019-09-04
A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)
Taipei Veterans General Hospital, Taiwan
Phase 4 Unknown
NCT01970748 2019-08-30
P-HCC
Taipei Veterans General Hospital, Taiwan
Phase 4 Unknown
NCT01504126 2019-08-29
Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT01988831 2019-05-10
Efficacy of Propranolol Treatment to Prevent Melanoma Progression
University Hospital, Geneva
Phase 2 Suspended
NCT03919461 2019-04-18
COMPIT-2
Assaf-Harofeh Medical Center
Phase 2 Recruiting
NCT03323710 2019-01-09
Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma
Military Institute od Medicine National Research Institute
Phase 2 Withdrawn
NCT01908972 2018-12-19
The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric Hemangioma
Seoul National University Hospital
Phase 4 Completed
NCT01074437 2018-10-04
Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)
Seattle Children's Hospital
Phase 2 Terminated
NCT03237637 2018-08-28
Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 3 Unknown
NCT01857817 2018-04-26
Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer
Vicus Therapeutics
Phase 2 Terminated
NCT03245554 2018-04-09
Clinical Research on Teratment of Gastrointestinal Cancer in the Preoperative by Propranolol
Central South University
Phase EARLY_PHASE1 Unknown
NCT02596867 2018-03-01
NPBC
Texas Tech University Health Sciences Center, El Paso
Phase 2 Terminated
NCT02104011 2018-01-23
STBETA
University Hospital, Bordeaux
Phase 2 Completed
NCT01705392 2017-02-24
Bevacizumab vs Dacarbazine in Metastatic Melanoma
Haukeland University Hospital
Phase 2 Terminated
NCT01308944 2017-01-12
Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients
Washington University School of Medicine
Phase 1 Completed
NCT02962947 2016-11-15
MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients
Azienda Sanitaria di Firenze
Phase 2/3 Unknown
NCT01743885 2016-06-01
Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma
University Hospital, Montpellier
Phase 3 Terminated